Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13

Multiple Sclerosis Journal

Volumn 19, Issue 7, 2013, Pages 863-870

  Linden M ^a   Khademi, M ^a   Lima Bomfim, I ^a   Piehl, F ^a   Jagodic, M ^a   Kockum, I ^a   Olsson, T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Biomarker; cerebrospinal fluid; CXCL13; disease progression; genetic susceptibility; HLA; multiple sclerosis; prognosis; single nucleotide polymorphism

Indexed keywords

CXCL13 CHEMOKINE; HLA A ANTIGEN; HLA DRB1 ANTIGEN; INTERFERON REGULATORY FACTOR 5;

ARTICLE; CEREBROSPINAL FLUID LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84873458628     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512463482     Document Type: Article

References (35)

1. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 ; 476: 214-219
2. Krumbholz M, Theil D, Cepok S, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006 ; 129: 200-211
3. Kuenz B, Lutterotti A, Ehling R, et al. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One. 2008 ; 3: e2559
4. Rupprecht TA, Pfister HW, Angele B, et al. The chemokine CXCL13 (BLC): A putative diagnostic marker for neuroborreliosis. Neurology. 2005 ; 65: 448-450
5. Courtioux B, Pervieux L, Vatunga G, et al. Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis. Trop Med Int Health. 2009 ; 14: 529-534
6. Brettschneider J, Czerwoniak A, Senel M, et al. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One. 2010 ; 5: e11986
7. Khademi M, Kockum I, Andersson ML, et al. Cerebrospinal fluid CXCL13 in multiple sclerosis: A suggestive prognostic marker for the disease course. Mult Scler. 2011 ; 17: 335-343
8. Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med. 2008 ; 358: 676-688
9. Kappos L, Li D, Calabresi PA, et al. Ocrelizumab in relapsing-remitting multiple sclerosis: A phase 2, randomised, placebo-controlled, multicentre trial. Lancet. 2011 ; 378: 1779-1787
10. Marta M, Stridh P, Becanovic K, et al. Multiple loci comprising immune-related genes regulate experimental neuroinflammation. Genes Immun. 2010 ; 11: 21-36
11. Jagodic M, Marta M, Becanovic K, et al. Resolution of a 16.8-Mb autoimmunity-regulating rat chromosome 4 region into multiple encephalomyelitis quantitative trait loci and evidence for epistasis. J Immunol. 2005 ; 174: 918-924
12. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tiss Antigens. 1992 ; 39: 225-235
13. Gamazon ER, Zhang W, Konkashbaev A, et al. SCAN: SNP and copy number annotation. Bioinformat. 2010 ; 26: 259-262
14. Xia K, Shabalin AA, Huang S, et al. SeeQTL: A searchable database for human eQTLs. Bioinformat. 2012 ; 28: 451-452
15. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007 ; 81: 559-575
16. Benjamini Y, Hochberg Y.. Controlling the false discovery rate - A practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995 ; 57: 289-300
17. Kristjansdottir G, Sandling JK, Bonetti A, et al. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet. 2008 ; 45: 362-369
18. Cavanillas ML, Alcina A, Nunez C, et al. Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk. Eur J Hum Genet. 2010 ; 18: 794-799
19. Alcina A, Vandenbroeck K, Otaegui D, et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun. 2010 ; 11: 439-445
20. Nohra R, Beyeen AD, Guo JP, et al. RGMA and IL21R show association with experimental inflammation and multiple sclerosis. Genes Immun. 2010 ; 11: 279-293
21. Jagodic M, Colacios C, Nohra R, et al. A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis. Sci Transl Med. 2009 ; 1: 10-21
22. IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun. 2010 ; 11: 397-405
23. Barcellos LF, Oksenberg JR, Begovich AB, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet. 2003 ; 72: 710-716
24. Sellebjerg F, Jensen J, Madsen HO, et al. HLA DRB1*1501 and intrathecal inflammation in multiple sclerosis. Tiss Antigens. 2000 ; 55: 312-318
25. Moratz C, Kang VH, Druey KM, et al. Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes. J Immunol. 2000 ; 164: 1829-1838
26. Moratz C, Hayman JR, Gu H, et al. Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice. Mol Cell Biol. 2004 ; 24: 5767-5775
27. Tran T, Paz P, Velichko S, et al. Interferon beta-1b induces the expression of RGS1, a negative regulator of G-Protein signaling. Int J Cell Biol. 2010 ; 2010: 529376
28. Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by toll-like receptors. Nature. 2005 ; 434: 243-249
29. Vosslamber S, Van der Voort LF, Van den Elskamp IJ, et al. Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of interferon beta therapy in multiple sclerosis. Genes Immun. 2011 ; 12: 466-472
30. Mancl ME, Hu G, Sangster-Guity N, et al. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem. 2005 ; 280: 21078-21090
31. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008 ; 40: 955-962
32. Musone SL, Taylor KE, Lu TT, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008 ; 40: 1062-1064
33. Filippi A, Tiso N, Deflorian G, et al. The basic helix-loop-helix olig3 establishes the neural plate boundary of the trunk and is necessary for development of the dorsal spinal cord. Proc Natl Acad Sci USA. 2005 ; 102: 4377-4382
34. Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004 ; 430: 694-699
35. Kool M, Van Loo G, Waelput W, et al. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity. 2011 ; 35: 82-96